Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06602141 · ClinicalTrials.gov registry record · NA

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

A NA study of Obesity, sponsored by AdventHealth Translational Research Institute.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
2
Study locations

NCT06602141: Recruiting NA study of Obesity, sponsored by AdventHealth Translational Research Institute.

NCT06602141 is a NA study of Obesity that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 70 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06602141, a NA study of Obesity, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research study is to study the effects of endurance exercise training on adipose (fat) tissue quality and insulin sensitivity in men and women.

Primary Outcome

A subcutaneous white adipose tissue biopsy from the abdomen will be collected before and after 12 weeks of deuterium (2H) labelled water administration and either endurance exercise training or control (no exercise). New adipocyte formation will be assessed on frozen isolated 2H2O labelled adipose tissue cells

Conditions Studied

Interventions

  • PROCEDURE Muscle Biopsy
  • PROCEDURE Adipose Biopsy
  • OTHER Glucose Clamp
  • OTHER Accelerometer
  • OTHER Endurance Exercise

Study Locations (2)

Florida

  • AdventHealth Translational Research Institute - Orlando

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-09-11
Est. Completion 2029-04
Phase NA

What NCT06602141 shows while recruiting

NCT06602141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Muscle Biopsy is the first listed.

NCT06602141 reports a single indexed study location in Florida, Louisiana.

Frequently Asked Questions

What is clinical trial NCT06602141 about?

NCT06602141 is a clinical study titled "Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise". The purpose of this research study is to study the effects of endurance exercise training on adipose (fat) tissue quality and insulin sensitivity in men and women.

What is the current status of trial NCT06602141?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-09-11. Estimated completion is 2029-04.

What conditions does trial NCT06602141 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT06602141?

The interventions under investigation include: Muscle Biopsy (PROCEDURE), Adipose Biopsy (PROCEDURE), Glucose Clamp (OTHER), Accelerometer (OTHER), Endurance Exercise (OTHER).

Who is sponsoring clinical trial NCT06602141?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06602141 being conducted?

This trial has 2 study locations across Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06602141's enrollment target sits among peer trials

70 595th of 1053 higher than 449 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06602141, the US trial registry maintained by the National Library of Medicine. NCT06602141 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.